Compare USNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USNA | EYPT |
|---|---|---|
| Founded | 1992 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.9M | 1.5B |
| IPO Year | 1996 | 2005 |
| Metric | USNA | EYPT |
|---|---|---|
| Price | $20.49 | $16.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $36.00 | $29.60 |
| AVG Volume (30 Days) | 173.0K | ★ 1.1M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $912,670,000.00 | $42,339,000.00 |
| Revenue This Year | $9.87 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.73 | ★ N/A |
| Revenue Growth | ★ 5.88 | N/A |
| 52 Week Low | $18.48 | $3.91 |
| 52 Week High | $38.32 | $19.11 |
| Indicator | USNA | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 60.28 |
| Support Level | $19.33 | $15.97 |
| Resistance Level | $21.11 | $19.11 |
| Average True Range (ATR) | 0.60 | 0.96 |
| MACD | 0.25 | 0.11 |
| Stochastic Oscillator | 66.40 | 46.36 |
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.